Cargando…
Emerging new therapeutic antibody derivatives for cancer treatment
Monoclonal antibodies constitute a promising class of targeted anticancer agents that enhance natural immune system functions to suppress cancer cell activity and eliminate cancer cells. The successful application of IgG monoclonal antibodies has inspired the development of various types of therapeu...
Autores principales: | Jin, Shijie, Sun, Yanping, Liang, Xiao, Gu, Xinyu, Ning, Jiangtao, Xu, Yingchun, Chen, Shuqing, Pan, Liqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821599/ https://www.ncbi.nlm.nih.gov/pubmed/35132063 http://dx.doi.org/10.1038/s41392-021-00868-x |
Ejemplares similares
-
TCR-mimic antibody-drug conjugates targeting intracellular tumor-specific mutant antigen KRAS G12V mutation
por: Shen, Ying, et al.
Publicado: (2020) -
Structure-guided and phage-assisted evolution of a therapeutic anti-EGFR antibody to reverse acquired resistance
por: Zhuang, Xinlei, et al.
Publicado: (2022) -
Facile Generation of Potent Bispecific Fab via Sortase A and Click Chemistry for Cancer Immunotherapy
por: Bai, Xuefei, et al.
Publicado: (2021) -
Intracellular trafficking of new anticancer therapeutics: antibody–drug conjugates
por: Kalim, Muhammad, et al.
Publicado: (2017) -
Transcytosis, Antitumor Activity and Toxicity of Staphylococcal Enterotoxin C2 as an Oral Administration Protein Drug
por: Zhao, Wenbin, et al.
Publicado: (2016)